These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1329674)
41. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. Sasaki H; Kobayashi M; Pollard RB; Suzuki F Pathobiology; 2001; 69(2):96-103. PubMed ID: 11752903 [TBL] [Abstract][Full Text] [Related]
42. Rapid development of murine AIDS is dependent of signals provided by CD54 and CD11a. Makino M; Yoshimatsu K; Azuma M; Okada Y; Hitoshi Y; Yagita H; Takatsu K; Komuro K J Immunol; 1995 Jul; 155(2):974-81. PubMed ID: 7608573 [TBL] [Abstract][Full Text] [Related]
43. Analysis of the capacity to produce IL-3 in murine AIDS. Neuenschwander AU; Marker O; Thomsen AR Scand J Immunol; 1994 Oct; 40(4):410-4. PubMed ID: 7939413 [TBL] [Abstract][Full Text] [Related]
44. An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. Uehara S; Hitoshi Y; Numata F; Makino M; Howard M; Mizuochi T; Takatsu K Int Immunol; 1994 Dec; 6(12):1937-47. PubMed ID: 7696211 [TBL] [Abstract][Full Text] [Related]
45. Population dynamics of CD4+ T cells lacking Thy-1 in murine retrovirus-induced immunodeficiency syndrome (MAIDS). Moutschen MP; Colombi S; Deprez M; Van Wijk F; Hotermans C; Martin MT; Greimers R; Boniver J Scand J Immunol; 1994 Feb; 39(2):216-24. PubMed ID: 7507599 [TBL] [Abstract][Full Text] [Related]
46. Contribution of Thy-1-CD4+ T cells to the disorganization of lymphoid follicles in retrovirus-induced immunodeficiency syndrome, MAIDS. Masuda A; Makino M; Kasajima T Clin Immunol Immunopathol; 1996 Dec; 81(3):253-60. PubMed ID: 8938102 [TBL] [Abstract][Full Text] [Related]
48. Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans. Furukawa K; Sasaki H; Pollard RB; Suzuki F J Antimicrob Chemother; 2000 Sep; 46(3):443-50. PubMed ID: 10980172 [TBL] [Abstract][Full Text] [Related]
49. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells. Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226 [TBL] [Abstract][Full Text] [Related]
50. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. Peeler JS; Niederkorn JY J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767 [TBL] [Abstract][Full Text] [Related]
51. Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression. Chien H; Alston CI; Dix RD J Virol; 2018 Sep; 92(18):. PubMed ID: 29976680 [TBL] [Abstract][Full Text] [Related]
52. Chemical sympathectomy has no effect on the severity of murine AIDS: murine AIDS alone depletes norepinephrine levels in infected spleen. Kelley SP; Moynihan JA; Stevens SY; Grota LJ; Felten DL Brain Behav Immun; 2002 Apr; 16(2):118-39. PubMed ID: 11908922 [TBL] [Abstract][Full Text] [Related]
53. Cytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome. Erbe JG; Green KA; Crassi KM; Morse HC; Green WR J Virol; 1992 May; 66(5):3251-6. PubMed ID: 1560546 [TBL] [Abstract][Full Text] [Related]
54. Cytotoxic T lymphocytes directed against MAIDS-associated tumors and cells from mice infected by the LP-BM5 MAIDS defective retrovirus. Green WR; Crassi KM; Schwarz DA; Green KA Virology; 1994 Apr; 200(1):292-6. PubMed ID: 8128630 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of murine AIDS (MAIDS), development by the transplantation of bone marrow cells carrying the Fv-4 resistance gene to MAIDS virus-infected mice. Nakagawa Y; Kakimi K; Ling W; Kubo Y; Higo K; Masuda T; Kuribayashi K; Iwashiro M; Komatz Y; Hirama T J Virol; 1994 Mar; 68(3):1438-41. PubMed ID: 8107206 [TBL] [Abstract][Full Text] [Related]
56. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. Beilharz MW; Sammels LM; Paun A; Shaw K; van Eeden P; Watson MW; Ashdown ML J Immunol; 2004 Apr; 172(8):4917-25. PubMed ID: 15067071 [TBL] [Abstract][Full Text] [Related]
57. A unique subset of normal murine CD4+ T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Holmes KL; Morse HC; Makino M; Hardy RR; Hayakawa K Eur J Immunol; 1990 Dec; 20(12):2783-7. PubMed ID: 1980114 [TBL] [Abstract][Full Text] [Related]
58. Evidence that the murine AIDS defective virus does not encode a superantigen. Doyon L; Simard C; Sékaly RP; Jolicoeur P J Virol; 1996 Jan; 70(1):1-9. PubMed ID: 8523511 [TBL] [Abstract][Full Text] [Related]
59. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Kanagawa O; Vaupel BA; Gayama S; Koehler G; Kopf M Science; 1993 Oct; 262(5131):240-2. PubMed ID: 8211142 [TBL] [Abstract][Full Text] [Related]
60. Oral carriage of Candida albicans in murine AIDS. Deslauriers N; Côté L; Montplaisir S; de Repentigny L Infect Immun; 1997 Feb; 65(2):661-7. PubMed ID: 9009328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]